Curis
CRIS
#11081
Rank
NZ$1.14 M
Marketcap
NZ$0.59
Share price
-17.89%
Change (1 day)
-78.97%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$40.19

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$40.50. In 2025 the company made an earnings per share (EPS) of NZ-$40.50 an increase over its 2024 EPS that were of NZ-$239.23.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$40.19-0.76%
2025NZ-$40.50-83.07%
2024NZ-$239.23-22.15%
2023NZ-$307.29-26.17%
2022NZ-$416.1922.3%
2021NZ-$340.30-25.37%
2020NZ-$456.00-30.93%
2019NZ-$660.18-2.02%
2018NZ-$673.79
2016NZ-$1,531-10%
2015NZ-$1,702138.1%
2014NZ-$714.6340%
2013NZ-$510.45-25%
2012NZ-$680.6066.67%
2011NZ-$408.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.23-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.06-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.33-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.25-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$8.58-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$0.29-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA